Clinical manifestations and spinal cord magnetic resonance imaging findings in chinese neuromyelitis optica patients

European Neurology

Volumn 71, Issue 1-2, 2014, Pages 35-41

  Lin, Aiyu ^a   Zhu, Jiting ^a   Yao, Xiaoping ^a   Lin, Shifang ^a   Murong, Shenxing ^a   Li, Zhiwen ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Anti AQP4 antibody; Clinical manifestations; Magnetic resonance imaging; Neuromyelitis optica

Indexed keywords

ADULT; AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CHINA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; SPINAL CORD; VISION DISORDERS; YOUNG ADULT;

AQUAPORIN 4 ANTIBODY;

ADULT; ARTICLE; CERVICAL SPINAL CORD; CHINESE; CLINICAL FEATURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONSET AGE; OPTIC NEURITIS; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SERODIAGNOSIS; SPINAL CORD LESION; SPINAL PARALYSIS; THORACIC SPINAL CORD; YOUNG ADULT;

EID: 84894470070     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000353983     Document Type: Article

References (29)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
2. Yokote H, Yagi Y, Watanabe Y, Amino T, Kamata T, Mizusawa H: Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI. J Neuroimmunol 2013; 259: 92-95.
3. Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO: Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study. BMC Neurol 2013; 13: 33.
4. Kim W, Kim SH, Kim HJ: New insights into neuromyelitis optica. J Clin Neurol 2011; 7: 115-127.
5. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
6. Morrow MJ, Wingerchuk D: Neuromyelitis optica. J Neuroophthalmol 2012; 32: 154-166.
7. Misu T, Takahashi T, Nakashima I, Fujihara K: Biomarkers in neuromyelitis optica. Brain Nerve 2012; 64: 525-535.
8. Benavente E, Paira S: Neuromyelitis optica-AQP4: an update. Curr Rheumatol Rep 2011; 13: 496-505.
9. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG: NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008; 70: 2197-2200.
10. Akman-Demir G, Tuzlln E: Prognostic implications of aquaporin 4 antibody status in neuromyelitis optica patients. J Neurol 2011; 258: 464-470.
11. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neummyelitis optica. Neurology 2006; 66: 1485-1489.
12. Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M: Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013; 80: 2210-2216.
13. Etemadifar M, Abtahi MA, Razmjoo H, Abtahi SH, Dehghani AR, Abtahi ZA, Akbari M, Mazaheri S, Maghzi AH: Anti-aquaporin-4 IgG in patients presenting with unilateral optic neuritis: a cohort study. Int J Prev Med 2012; 3: 612-615.
14. Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q: The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 2013; 20: 94-98.
15. Salazar R, Cerghet M, Shad A, Markowitz NP: NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient. Clin Neurol Neurosurg 2013; 13: 107-108.
16. Fujihara K, Leite MI: Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challenges. Neurology 2013; 80: 2176-2177.
17. Kim YJ, Jung SW, Kim Y, Park YJ, Han K, Oh EJ: Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissuebased and cell-based indirect immunofluorescence assays and ELISA. J Clin Lab Anal 2012; 26: 184-189.
18. Wu L, Yang Y, Huang D, et al: Magnetic resonance characteristics of cord lesions and brain abnormality in magnetic imaging spinal Chinese with patients neuromyelitis optica. J South Med Univ 2010; 30: 2733-2737.
19. Li Y, Xie P, Lv F, et al: Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 2008; 118: 218-225.
20. Krampla W, Aboul-Enein F, Jecel J, et al: Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI followup study. Eur Radiol 2009; 19: 2535-2543.
21. Kira J: Neuromyelitis optica and Asian phenotype of multiple sclerosis. Ann NY Acad Sci 2008; 1142: 58-71.
22. Sellner J, Boggild M, Clanet M: EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010; 17: 1019-1032.
23. Wingerchuk DM, Weinshenker BG: Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003; 60: 848-853.
24. Mandler RN: Neuromyelitis optica-Devic's syndrome, update. Autoimmun Rev 2006; 5: 537-543.
25. Filippi M, Rocca MA: MR imaging of Devic's neuromyelitis optica. Neurol Sci 2004; 25:S371-S373.
26. Wingerehuk DM, Hoganeamp WF, O'Brien PC, et al: The clinical course of neuromyelitis optica (Devic' syndrome). Neurology 1999; 53: 1107-1114.
27. Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, Watanabe S, Takahashi T, Itoyama Y: Preferential spinal central gray matter involvement in neuromyelitis optica: an MRI study. J Neurol 2008; 255: 163-170.
28. Kiyat-Atamer A, Ekizo?lu E, Tuzun E, Kurtuncu M, Shugaiv E, Akman-Demir G, Eraksoy M: Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients. Eur J Neurol 2013; 205: 781-787.
29. Takano R, Misu T, Takahashi T, Izumiyama M, Fujihara K, Itoyama Y: A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica. Tohoku J Exp Med 2008; 2151: 55-59.